Detection of nuclear matrix proteins in serum from cancer patients - PubMed
- ️Wed Jan 01 1992
. 1992 Jan 15;52(2):422-7.
Affiliations
- PMID: 1728414
Detection of nuclear matrix proteins in serum from cancer patients
T E Miller et al. Cancer Res. 1992.
Abstract
Morphological characteristics of the cell nucleus have long been used by pathologists in the clinical diagnosis of cancer. The nuclear matrix of the cell, the structure that serves to organize the chromatin within the nucleus, is known to reflect these morphological characteristics with regard to cell and cancer type. Monoclonal antibodies were developed to extracted nuclear matrix proteins. These antibodies were used in two-site immunometric assays to detect soluble nuclear matrix proteins in the supernatants of two dying cell lines and 15 tumor tissues. Furthermore, nuclear matrix proteins were detected at elevated levels in the sera of cancer patients compared with normal patient sera. In one assay, 63.2% of cancer sera read above 95% of normal sera, and in another assay, 73.7% of cancer sera read above 95% of the normal sera. With the development of monoclonal antibodies with greater cancer specificity, the detection of circulating nuclear matrix proteins may become an important clinical tool in the diagnosis and monitoring of cancer.
Similar articles
-
Partin AW, Briggman JV, Subong EN, Szaro R, Oreper A, Wiesbrock S, Meyer J, Coffey DS, Epstein JI. Partin AW, et al. Urology. 1997 Nov;50(5):800-8. doi: 10.1016/S0090-4295(97)00337-3. Urology. 1997. PMID: 9372899
-
Identification of nuclear matrix protein alterations associated with human colon cancer.
Brünagel G, Vietmeier BN, Bauer AJ, Schoen RE, Getzenberg RH. Brünagel G, et al. Cancer Res. 2002 Apr 15;62(8):2437-42. Cancer Res. 2002. PMID: 11956108
-
Nuclear mitotic apparatus protein (NuMA) in benign and malignant diseases.
Hasholzner U, Stieber P, Zimmermann A, Burges A, Hofmann K, Schmitt UM, Schmeller N, Schalhorn A. Hasholzner U, et al. Anticancer Res. 1999 Jul-Aug;19(4A):2415-20. Anticancer Res. 1999. PMID: 10470168
-
Nuclear matrix proteins as cancer markers.
Davido T, Getzenberg RH. Davido T, et al. J Cell Biochem Suppl. 2000;Suppl 35:136-41. J Cell Biochem Suppl. 2000. PMID: 11389543 Review.
-
[Functional arrangement of genomic DNA and structure of nuclear matrix].
Hibino Y. Hibino Y. Yakugaku Zasshi. 2000 Jun;120(6):520-33. Yakugaku Zasshi. 2000. PMID: 10860485 Review. Japanese.
Cited by
-
Nuclear matrix, dynamic histone acetylation and transcriptionally active chromatin.
Davie JR. Davie JR. Mol Biol Rep. 1997 Aug;24(3):197-207. doi: 10.1023/a:1006811817247. Mol Biol Rep. 1997. PMID: 9291093 Review.
-
Bidwell J, McCabe R, Rougraff B, Feister H, Fey E, Onyia J, Holden J, Hock J. Bidwell J, et al. Mol Biol Rep. 1997 Nov;24(4):271-82. doi: 10.1023/a:1006883528518. Mol Biol Rep. 1997. PMID: 9403869
-
Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer.
Leman ES, Schoen RE, Magheli A, Sokoll LJ, Chan DW, Getzenberg RH. Leman ES, et al. Clin Cancer Res. 2008 Mar 1;14(5):1349-54. doi: 10.1158/1078-0432.CCR-07-4110. Clin Cancer Res. 2008. PMID: 18316554 Free PMC article. Retracted.
-
Sankhwar M, Singh R, Sankhwar SN, Goel MM, Jain A, Sankhwar PL. Sankhwar M, et al. World J Oncol. 2013 Jun;4(3):151-157. doi: 10.4021/wjon677w. Epub 2013 Jul 15. World J Oncol. 2013. PMID: 29147347 Free PMC article. Retracted.
-
TNF-alpha promotes caspase activation and apoptosis in human fetal membranes.
Menon R, Lombardi SJ, Fortunato SJ. Menon R, et al. J Assist Reprod Genet. 2002 Apr;19(4):201-4. doi: 10.1023/a:1014898130008. J Assist Reprod Genet. 2002. PMID: 12036088 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources